Progress in Reporting Conflict of Interest Among IRB Members

This article originally appeared here.
Share this content:
Progress in Reporting Conflict of Interest Among IRB Members
Progress in Reporting Conflict of Interest Among IRB Members

TUESDAY, July 14, 2015 (HealthDay News) -- Among institutional review board (IRB) members, there has been positive progress in the reporting and management of conflicts of interest, according to a study published online July 13 in JAMA Internal Medicine.

Eric G. Campbell, Ph.D., from Massachusetts General Hospital in Boston, and colleagues examined the nature, extent, and perceived consequences of industry relationships among IRB members in academic health centers. IRB members from the 115 most research-intensive medical schools and teaching hospitals were surveyed; questions were identical to those used in 2005.

The researchers found that the percentage of IRB members with an industry relationship did not change significantly from 2005 through 2014 (37.2 versus 32.1 percent; P = 0.09). There was a decrease in the percentage of members who felt another member did not properly disclose a financial relationship, from 10.8 percent in 2005 to 6.7 percent in 2014 (P = 0.04); the percentage who felt pressure from their institution or department to approve a protocol also decreased (18.6 to 10.0 percent; P < 0.001). There was no change in the percentage of members with a conflict of interest who voted on protocols with which they have a conflict; there was a significant increase in the percentage who said they always disclosed relationships (from 54.9 to 80.0 percent).

"Additional attention should be focused on deterring IRB members from inappropriately voting on or presenting protocols in a biased manner," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »